Related Experiment Video
Updated: May 28, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Genetic modifiers of sickle cell disease
1Department of Molecular Haematology, King's College London, London, UK. sl.thein@kcl.ac.uk
Genetic factors significantly influence sickle cell disease severity. Recent studies identify key genetic variants and Hb F genetics, improving disease prediction and guiding new therapies.
Area of Science:
- Genetics
- Hematology
- Molecular Biology
Background:
- Sickle cell disease (SCD) is a well-characterized monogenic disorder.
- Complex genotype/phenotype correlations indicate interactions between genetic and environmental factors.
- Understanding these interactions is crucial for managing SCD.
Purpose of the Study:
- To review recent genetic association studies on sickle cell disease modifiers.
- To highlight key genetic variants influencing SCD, including those related to Hb F.
- To discuss the implications of these findings for predicting disease severity and guiding therapy.
Main Methods:
- Review of recent genetic association studies.
- Analysis of identified genetic variants and their association with SCD phenotypes.
- Focus on genetic modifiers, particularly Hb F genetics.
Main Results:
- Identification of specific genetic variants that modify SCD severity.
- Elucidation of the role of Hb F genetics in SCD.
- Demonstration of complex genetic influences on SCD phenotypes.
Conclusions:
- Genetic factors play a significant role in modulating SCD severity.
- Identifying genetic modifiers can improve disease prediction and inform therapeutic strategies.
- Findings have implications for genetic counseling, prenatal diagnosis, and high-risk therapy.
Related Concept Videos
Multiple Allele Traits
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Pharmacogenomics: Identification of New Drug Targets
Genetic Lingo
Principles of Pharmacogenetics: Types of Genetic Variants
